Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports.

Felix Ampomah; Analyst; Stephens, Inc. Good morning ladies and gentlemen, and welcome to Fennec Pharmaceuticals fourth quarter and full year 2024 earnings and corporate update conference call.

Invincible is getting ready for a brand new story in Season 4 not seen in the original comics, and this could be the perfect ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year. Revenue declined to $7.93 ...

Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings and Corporate Update Conference Call. At this time, all participants are in a ...

Formed in the early 80s but languishing in obscurity after the tragic death of their frontman, Hell were one of metal’s great ...

Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $0.56. Operator: Good morning, ladies and gentlemen, and welcome to Fennec ...

Writer Ariel (Ayo Edebiri; The Bear) has worked at a music magazine for three years but in spite of coming up with great ...

FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$0.06 per share, missing estimates of $0.17 ...

(RTTNews) - Fennec Pharmaceuticals Inc (FENC) released Loss for fourth quarter that decreased from last year and beat the Street estimates. The company's earnings totaled -$1.62 million ...

Early Repayment of $13 Million of the Company’s Approximately $32 Million Outstanding Convertible Debt Facility: In December 2024, Fennec announced the early partial repayment of a significant ...

Don’t miss Greg Joyce’s text messages from spring training — he’s giving Sports+ subscribers the inside buzz on the Yankees. Spring is a time for optimism, but that’s in short supply now ...